Intermediates of neutral endopeptidase inhibitors and preparation method thereof

Details for Australian Patent Application No. 2011207020 (hide)

Owner Novartis AG

Inventors Hook, David; Zhou, Jianguang; Li, Yunzhong; Ku, Jie

Agent Davies Collison Cave

Pub. Number AU-A-2011207020

PCT Pub. Number WO2011/088797

Priority PCT/ CN2010/070322 22.01.10 CN

Filing date 21 January 2011

Wipo publication date 28 July 2011

International Classifications

C07D 207/277 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07C 227/22 Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 229/34 Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/263 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/267 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/088797 Priority application(s): WO2011/088797

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207043-A human factor IX slow release dosage form

2011206979-Treatment of cardiac conditions